Moderna
MRNAHealthcare · Biotechnology · US218.01USD-7.82%
StratDeckModerna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.
Price · Past year
Loading chart…
Checks
- Pass: Price trending up The figures
- Fail: Sales growing slower than its peers The figures
- Fail: Not making a profit The figures
- Fail: Analysts rate it a hold The figures
- Not known: Valuation not available
- Pass: Beat profit forecasts The figures
Share
Keep researching
Where next from MRNA
Other stocks you may like
Fundamentals
SEC EDGAR
Yahoo FinanceShowHide
What's happening?
MRNA is beating Healthcare this month The figures
- 1D
- -7.82%
- 7D
- -3.11%
- 1M
- +49.71%
- 3M
- +252.65%
- 6M
- +305.83%
- YTD
- +639.27%
What is the market expecting?
Expected to make a loss, and analysts expect the price to fall The figures
Not ranked on value: this stock carries too few of the multiples to score against its sector.
Is the business delivering?
Sales are growing slower than at similar companies The figures
Earnings by quarter
Latest quarter -782M · +561M on the quarter before · +43.0M on a year earlier
- 13.0MNov24+1.29B
- -1.12BFeb25-1.13B
- -971MMay25+149M
- -825MAug25+146M
- -200MNov25+625M
- -826MFeb26-626M
- -1.34BMay26-517M
- -782MJul26+561M
How does it compare?
Value rankingMRNA is not ranked on value
What happens next?
Reports next on 6 Nov, in 20 days
Daily market updates
Get the brief
Get an interesting stock pick, updates on the AI sector, information on the biggest movers of the day, and more, in the Monday, Wednesday and Friday email.